Two straight nights of record COVID-19 hospitalization numbers have hit Oklahoma two weeks after the state ended its overflow contracts with hospitals.
As flu season nears, public health and medical professionals are concerned about strained hospital capacity and staffing shortages in Oklahoma, especially regarding intensive-care beds. Oklahoma posted a record 738 hospitalizations overnight Monday, topping the prior record of 699 set only a day earlier.
The high before this week was the 663 hospitalizations reported July 28. COVID-19 hospitalizations consist of confirmed cases and those suspected of having the illness.
The numbers of COVID-19 patients in state ICUs the past two weeks have been relatively stable, bouncing between 220 and 245. However, state data released Tuesday showed 258 COVID patients in ICUs — the third highest number yet. The peak was 281 on April 2.
People are also reading…
Of the state’s 1,021 ICU beds, 143 — or 14% — were available as of the latest hospital census by the state. The percent of ICU beds available has steadily declined since elective surgeries resumed April 24, with the highest percent available reported May 8 at 45%.
“We have a shortage in Oklahoma of nurses and physicians, and what we’re seeing is from time to time hospitals are going on divert (sending new patients to other hospitals) because they just don’t have that capacity either for ICU beds or COVID beds,” Dr. George Monks, president of the Oklahoma State Medical Association, said Tuesday. “That situation can change hourly, but it shows us that things are under strain.
“Staff, nurses, doctors are being asked to work longer hours and pick up more shifts because we have so many people in the hospital right now.”
Deputy Health Commissioner Travis Kirkpatrick said the Oklahoma State Department of Health is monitoring whether the record hospitalizations numbers are outliers or a trend that might “warrant further consideration or response.”
In a written response to questions, Kirkpatrick said ending the overflow contracts was a fiscally prudent move to build “something more sustainable” before federal CARES Act funds are exhausted by Dec. 31 rather than use them on the “short-term bed contracts.” He said the decision will be revisited if necessary and that there are “back-up bed options” if a surge of patients goes beyond capacity.
Previously, state officials had described the overflow contracts as a good insurance policy for the state to be open and not risk overwhelming the hospital system.
Overflow contracts with seven hospitals were designed to pay each to guarantee the necessary staffing should an overflow bed be needed by underwriting overtime or bonuses, new staff or contract workers. The contracts — $1,000 a bed per day or $3,000 if occupied — were funded by the CARES Act.
“We cannot and will not turn patients away,” said LaWanna Halstead, vice president of quality and clinical initiatives for the Oklahoma Hospital Association.
Halstead explained that hospitals still retain their internal surge plans but no longer are supported by state funding since the end of September.
She said some nursing staff, especially temporary staff, go to COVID-19 hot spots for more money. She said the largest concern confronting hospitals in Oklahoma is the ability to appropriately manage capacity through staff.
“We do hear from hospitals that their staff is pretty weary of the extreme capacity and conditions that they’re dealing with, having to always wear the (personal protective equipment),” Halstead said.
“We don’t want to wear a mask for an hour, and yet hospital staff wear it for eight- or 12-hour shifts at a time. The full PPE, with masks and gowns and gloves. So it is wearing on the staff.”
She noted that hospitals probably will need to work closely with their specialty partners, such as rehabilitation or skilled nursing, on a more rapid basis. They also might have to eliminate elective surgeries, which no one wants to do because that isn’t good for public health, she said.
Lt. Col. Matt Stacy, who coordinated the state’s surge strategy, acknowledged that the optics of the timing are unfortunate. He said the state gave 10-days’ notice to hospitals that the overflow contracts would end Sept. 21.
Stacy said the state felt it had given hospitals enough financial support with the $1,000 per bed per day standby rate during the initial 60-day contract term.
Stacy, who is on the Governor’s Solution Task Force, said hospitals are “in good shape” and that it’s important to remember that they are still performing elective or nonemergency surgeries.
“I’m not saying the COVID patients don’t stress them to some extent, because it does. It does stress them,” Stacy said. “But it’s not detrimental to the health system. Our intent with the surge money was to make sure that we didn’t have a situation that was detrimental to the health system.
“We felt like they were able to manage with the resources that they have and the resources that we provided them over a couple months.”
Monks said the state’s high test positivity rate is an indicator that more hospitalizations loom.
The White House Coronavirus Task Force in its Sept. 27 report ranked Oklahoma No. 3 in the U.S. for weekly test positivity rate. Oklahoma’s rate was 11.8% while the national average was 4.3%.
Monks said Oklahoma City and central Oklahoma currently seem to have the hospital systems or regions under the most pressure.
Dr. Dale Bratzler, OU’s chief COVID officer, on Friday described how recently a few patients from the Oklahoma City area were transferred to Tulsa hospitals because finding ICU beds there “was getting difficult” for a short period of time.
Bratzler also said Stillwater Medical Center had been taking transfers from smaller community hospitals that don’t have the capability or ICU beds to care for COVID-19 patients, prompting the facility to open about five more beds.
Gov. Kevin Stitt routinely says the state has plenty of surge capacity. So how did Oklahoma City-area hospitals fill up enough, albeit for a limited time, to prompt patient transfers to Tulsa?
Fitzpatrick said each hospital “has the flexibility to adapt based on the circumstances every day” and that the state monitors data but doesn’t control or mandate transfer decisions, patient treatment decisions or daily hospital staffing.
Surge plans are in place for Oklahoma City that can be activated if needed to increase hospital capacity, he said.
“We work closely with our hospitals to help manage capacity statewide,” Fitzpatrick stated. “We have ample capacity currently to ensure all Oklahomans who need to be hospitalized are able to receive top-notch care.”
Monks also pointed to what he called the “consistently high” seven-day average of new cases in Oklahoma, with the state topping 1,000 on Tuesday for the 16th time in 18 days.
After two days of lower numbers, 1,364 new cases were reported Tuesday — the second most in a day yet. The record is 1,401 reported July 27.
The seven-day average on Tuesday was 1,018, down from the record 1,136 on Sept. 25.
The longest consecutive stretch of seven-day averages above 1,000 was 15 days, from Sept. 19-Oct. 3. The previous longevity mark above 1,000 was six days from July 27-Aug. 1.
“One more worrisome statistic is in September we saw the rise in new cases in young patients,” Monks said. “We are now seeing a shift to those older, more vulnerable age groups making up these new cases, which is concerning. Those are people more likely to maybe need a hospital bed.”
Featured video: Most hospitalized COVID-19 patients have neurological symptoms
COVID-19 basics everyone needs to know as the pandemic continues
COVID-19 basics everyone needs to know as the pandemic continues
How it spreads, who's at risk
Studies have shown many infected people show no symptoms or have symptoms so mild they may go undetected; those people can still transmit COVID-19 to About 20% of patients diagnosed with COVID-19 require hospitalization.
The disease can be fatal, especially for vulnerable populations: those older than 65, living in a nursing home or long-term care facility, and anyone with underlying health conditions such as diabetes, heart disease, lung disease or obesity.
Science of virus spread
COVID-19 is spread mainly from person to person via respiratory droplets produced by an infected person. Spread is most likely when people are in close contact, within about 6 feet. A person might also be infected with COVID-19 after touching a surface or object that has the virus on it and then touching their face. According to the CDC, evidence suggests the novel coronavirus may remain viable for hours to days on surfaces, though that form of transmission is said to be minor.
Transmission between people more than 6 feet from one another may occur in poorly ventilated and enclosed spaces, the CDC says, especially where activities cause heavier breathing, such as singing or exercising.
The infectious period for patients can begin up to 48 hours before symptom onset.
List of symptoms
The CDC recently expanded its list of possible symptoms of COVID-19. The symptoms can appear from two days to two weeks after exposure.
- Fever or chills
- Cough
- Shortness of breath or difficulty breathing
- Fatigue
- Muscle or body aches
- Headache
- New loss of taste or smell
- Sore throat
- Congestion or runny nose
- Nausea or vomiting
- Diarrhea
This list does not include all possible symptoms and will continue to be updated by the CDC. One symptom not included is "purple toes," which someone may experience with no other symptoms, sometimes several weeks after the acute phase of an infection is over. The coloration and pain is caused by a lack of blood flow to the toes caused by excessive blood clotting, a late-stage concern with COVID-19 infections.
Kinds of testing
Those getting tested may experience different kinds of swabs. The viral test, known as PCR, involves a deep nasal swab that can be painful.
Other tests that require less-invasive swabs may produce results faster, but with less accuracy. These should not be used diagnostically.
It is not yet known whether COVID-19 antibodies can protect someone being infected again or how long protection might last.
The 'serious seven'
The "serious seven" refer to close contact environments where residents should take extra precautions if they choose to attend. The seven are gyms, weddings, house gatherings, bars, funerals, faith-based activities and other small events, according to Tulsa Health Department Director Bruce Dart.
Treatments being investigated
The FDA has allowed for antiviral drug remdesivir, previously tested on humans with Ebola, to treat more severe cases of COVID-19 in adults and children. Safety and effectiveness aside, preliminary studies have shown it can shorten recovery time for some patients.
After previously approving an emergency use authorization, the FDA as of July 1 cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial. A review of safety issues includes reports of serious heart rhythm problems and other safety issues, including blood and lymph system disorders, kidney injuries, and liver problems and failure.
Convalescent serum therapy
Some patients are receiving convalescent serum, meaning the antibodies made by people who have recovered after a COVID-19 infection. Antibody-rich blood plasma is being given to severely or critically ill COVID-19 patients, including Ascension St. John, Saint Francis Health System, OSU Center for Health Sciences and Hillcrest HealthCare System in Tulsa.
From June to July, requests for convalescent plasma from the Oklahoma Blood Institute multiplied seven-fold.
Recovery, as defined by CDC
To be considered recovered (without a test), these three things must happen, the CDC advises:
- No fever for at least 72 hours (three full days of normal temperature without the use of medicine)
- Other symptoms improved (no more cough, etc.)
- At least 10 days since symptoms first appeared






